Home
About
FAQ
History (29)
From rehabilitation to recovery: protocol for a randomised controlled trial evaluating a goal-based intervention to reduce depression and facilitate participation post-stroke.
Curative potential of chemoimmunotherapy in diffuse large B cell lymphoma with hepatic and/or renal dysfunction.
Complications of Methamphetamine Use in Orthopaedic Trauma.
A novel RPE65 inhibitor CU239 suppresses visual cycle and prevents retinal degeneration.
Position Paper on the Reporting of Norepinephrine Formulations in Critical Care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force.
See All 29 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (15)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Colin E. Bishop PhD
Wake Forest School of Medicine
Why?
Carol A. Shively PhD
Wake Forest School of Medicine
Why?
Ronald L. Davis MD
Wake Forest School of Medicine
Why?
Richard B. Weinberg MD
Wake Forest School of Medicine
Why?
James E. Johnson PhD
Wake Forest School of Medicine
Why?
Stephen Kritchevsky PhD
Wake Forest School of Medicine
Why?
Peiqing Sun PhD
Wake Forest School of Medicine
Why?
Adrian W. Laxton MD
Wake Forest School of Medicine
Why?
Ryan M. Drenan PhD
Wake Forest School of Medicine
Why?
Anthony Atala MD
Wake Forest School of Medicine
Why?
Xue Ma PhD, MD
Wake Forest School of Medicine
Why?
Herbert L. Bonkovsky MD
Wake Forest School of Medicine
Why?
Kimberly D. Reeves PhD
Wake Forest School of Medicine
Why?
Osvaldo Delbono MD, PhD
Wake Forest School of Medicine
Why?
Michael C. Seeds PhD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 1
Next
Prev
Search Criteria
Mammals
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions